IP Library Granted Patent US 8,541,580
Granted Patent B2
US 8,541,580 · App. 12/938,297 · Granted Sep 24, 2013

Process for the preparation of pyrazinone thrombin inhibitor and its intermediates

Inventors: Reguri Buchi Reddy (Morris Plains, NJ); Upparapalli Sampathkumar (Morris Plains, NJ); Nilam Sahu (Morris Plains, NJ); Jawaji Karunakara Rao (Morris Plains, NJ); Gade Brahma Reddy (Morris Plains, NJ)
Assignee: Diakron Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,541,580
App. No.
12/938,297
Granted
Sep 24, 2013
Kind
B2
Abstract

Improved process for the preparation of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide of formula (I) and its intermediates is provided.

Claims (18)

1. In a process for the preparation of a compound of formula (I):

wherein 2,2-difluoro-2-(2-pyridyl)ethylamine or its salt is reacted with ethyl 3-chloropyrazin(1H)-2-one-1-acetate to form ethyl 3 -(2,2-difluoro-2-(2-pyridyl)ethylamino)-pyrazin(1H)-2-one- 1-acetate, which is chlorinated to form:

which is further reacted with 2-aminomethyl-3-fluoropyridine or its salt to form 3-fluoro-2-pyridylmethyl-3 -(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one- 1 -acetamide, the compound of formula (I), the improvement comprising:

reducing 2-cyano-3-fluoropyridine with Raney Nickel in the presence of an acid to form 2-aminomethyl-3-fluoropyridine or its salt;

reacting 2,2-difluoro-2-pyridin-2-ylethanol with 4-toluenesulfonyl chloride to form 2,2-difluoro-2-pyridin-2-ylethyl 4-methylbenzenesulfonate, which is converted to 2,2-difluoro-2-(2-pyridyl)ethylamine or its salt by reacting with ammonia; and

optionally purifying the compound of formula (I) by addition of an organic solvent.

2. The process of claim 1 , wherein the salt of 2-aminomethyl-3-fluoropyridine or 2,2-difluoro-2-(2-pyridyl)ethylamine — comprises one or more selected from the group consisting of a hydrochloride, hydrobromide and benzenesulphonate.

3. The process of claim 1 , wherein the acid used in reducing 2-cyano-3-fluoropyridine comprises acetic acid or trifluoroacetic acid.

4. The process of claim 1 , wherein the organic solvent is selected from the group consisting of a ketone, alcohol, ester, ether, hydrocarbon, halogenated solvent and a mixture thereof.

5. The process of claim 4 , wherein the ketone is acetone or butanone.

6. The process of claim 4 , wherein the alcohol is selected from the group consisting of methanol, ethanol, n-propanol, isopropanol (IPA), n-butanol, t-butanol, hexanol and isoamyl alcohol.

7. The process of claim 4 , wherein the ester is selected from the group consisting of ethyl acetate, methyl acetate and isopropyl acetate.

8. The process of claim 4 , wherein the ether is diisopropyl ether or methyl t-butyl ether (MTBE).

9. The process of claim 4 , wherein the hydrocarbon is selected from the group consisting of hexane, heptane, cyclohexane, decalin and pentane.

10. The process of claim 4 , wherein the halogenated solvent is dichloromethane (MDC) or 1,2-dichloroethane.

11. The process of claim 4 , wherein the organic solvent is acetone, isopropyl alcohol or a mixture thereof.

12. The compound 2,2-difluoro-2-pyridin-2-ylethyl 4-methylbenzenesulfonate.

13. A process for the preparation of 2,2-difluoro-2-pyridin-2-ylethyl 4-methylbenzenesulfonate, comprising reacting 2,2-difluoro-2-pyridin-2-ylethanol with 4-toluenesulfonyl chloride.

Assignments (4)
SECURITY INTEREST Recorded Dec 20, 2018
From: DIAKRON PHARMACEUTICALS, INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 048681/0011 →
SECURITY INTEREST TERMINATION Recorded Apr 21, 2015
From: KNOBBE, MARTENS, OLSON & BEAR, LLP
To: DIAKRON PHARMACEUTICALS, INC.
Reel/Frame 035475/0654 →
SECURITY INTEREST Recorded Oct 13, 2014
From: DIAKRON PHARMACEUTICALS, INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 033976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2010
From: REDDY, REGURI BUCHI; SAMPATHKUMAR, UPPARAPALLI; SAHU, NILAM; RAO, JAWAJI KARUNAKARA; REDDY, GADE BRAHMA
To: DIAKRON PHARMACEUTICALS, INC.
Reel/Frame 025504/0651 →
Priority Claims (1)
IN 2663/CHE/2009 · Nov 3, 2009 · national
Continuity (1)
Related Publication 20110105753A1 · May 5, 2011